Ubiquitin-specific peptidase 22 controls integrin-dependent cancer cell stemness and metastasis

Kun Liu,Qiong Gao,Yuzhi Jia,Juncheng Wei,Shuvam Mohan Chaudhuri,Shengnan Wang,Amy Tang,Nikita Lavanya Mani,Radhika Iyer,Yang Cheng,Beixue Gao,Weiyuan Lu,Zhaolin Sun,Bin Zhang,Huiping Liu,Deyu Fang

DOI: https://doi.org/10.1016/j.isci.2024.110592

IF: 5.8

2024-07-27

iScience

Abstract:Integrins play critical roles in connecting the extracellular matrix and actin. While the upregulation of integrins is thought to promote cancer stemness and metastasis, the mechanisms underlying their upregulation in cancer stem cells (CSCs) remain poorly understood. Herein, we show that USP22 is essential in maintaining breast cancer cell stemness by promoting the transcription of integrin β1 (ITGB1). Both genetic and pharmacological inhibition of USP22 largely impaired breast CSCs self-renewal and prevented their metastasis. Reconstitution of integrin β1 partially rescued USP22-null breast cancer metastasis. USP22 functions as a bona fide deubiquitinase to protect the proteasomal degradation of the forkhead box M1 (FoxM1), a transcription factor for tumoral ITGB1 gene transcription. Immunohistochemistry staining detected a positive correlation among USP22, FoxM1, and integrin β1 in human breast cancers. Collectively, our study identifies the USP22-FoxM1-integrin β1 signaling axis as critical for cancer stemness and offers a potential target for antitumor therapy.